^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CIMAbior (rituximab biosimilar)

i
Other names: 1B8
Associations
Trials
Company:
Center of Molecular Immunology
Drug class:
CD20 inhibitor
Related drugs:
Associations
Trials